Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis

BACKGROUND: Accumulating evidence suggests that patients with type 2 diabetes mellitus and hyperinsulinemia are at an increased risk of developing malignancies. It remains to be fully elucidated whether the use of metformin, an insulin sensitizer, and/or sulfonylureas, insulin secretagogues, affects...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekuria, Abraham Nigussie, Ayele, Yohanes, Tola, Assefa, Mishore, Kirubel Minsamo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885827/
https://www.ncbi.nlm.nih.gov/pubmed/31828167
http://dx.doi.org/10.1155/2019/7676909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885827/
https://www.ncbi.nlm.nih.gov/pubmed/31828167
http://dx.doi.org/10.1155/2019/7676909

Ejemplares similares